Javelin Pharmaceuticals
Javelin Pharmaceuticals's email is info@javelinpharma.com
and
Javelin Pharmaceuticals's phone number is 617-349-4500
.
Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the U...
read more
Javelin Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and commercialization of products for the pain management market primarily in the United States and Europe. Its products focus on treating various pain disorders ranging from acute and episodic moderate-to-severe pain associated with breakthrough cancer pain, post-operative pain, post-trauma pain (orthopedic injury pain), procedural pain, and burn pain. The company's Dyloject (injectable diclofenac) received approval for marketing to treat post-operative pain in the United Kingdom and was licensed to Therabel Pharma N.V. for commercialization in the European Union and certain other countries outside the United States. Its products in the Phase 3 development stage in the U.S. include Dyloject (diclofenac sodium injectable), an injectable formulation of diclofenac and a prescription nonsteroidal anti-inflammatory drug that is used to treat post-operative pain due to its combination of effectiveness and tolerability; Ereska (intranasal ketamine), a proprietary nasal formulation; and Rylomine (intranasal morphine) for treatment of acute moderate-to-severe pain, including breakthrough pain. Javelin Pharmaceuticals has license agreements with Shimoda Biotech, Ltd. to develop and commercialize products related to a proprietary formulation of the injectable delivery of diclofenac; and West Pharmaceutical Services, Inc. to develop and commercialize intranasal morphine for the transmucosal delivery of morphine to humans and animals for the treatment of pain. The company was founded in 1998 and is based in Cambridge, Massachusetts.
show less
Website | jabeau.com.au | |
Industry | Pharmaceuticals | |
Employees | 16 |
HQ | 125 CambridgePark Drive | |
Phone | 617-349-4500 | |
info@javelinpharma.com | ||
Funding | 32,750,000 USD | |
Competitors | Walgreens Boots Allia..., Pfizer, Cvs Health, Novartis, Gsk, Bayer, |
Website | jabeau.com.au | |
Industry | Pharmaceuticals | |
Employees | 16 | |
linkedin.com/company/javelin-pharmaceuticals | ||
HQ | 125 CambridgePark Drive | |
Phone | 617-349-4500 | |
info@javelinpharma.com | ||
Funding | 32,750,000 USD |
Top Competitors for Javelin Pharmaceuticals
Javelin Pharmaceuticals Questions
Where are Javelin Pharmaceuticals's headquarters?
Javelin Pharmaceuticals's headquarters are in 125 CambridgePark Drive
What is Javelin Pharmaceuticals's phone number?
Javelin Pharmaceuticals's phone number is 617-349-4500
What is Javelin Pharmaceuticals's official website?
Javelin Pharmaceuticals's website is jabeau.com.au
How many employees are working in Javelin Pharmaceuticals right now?
Javelin Pharmaceuticals has
16 employees.
View the Email and Phone Numbers for all 16 working at Javelin Pharmaceuticals.
What is Javelin Pharmaceuticals's industry?
Javelin Pharmaceuticals's industry is
Pharmaceuticals
Who are Javelin Pharmaceuticals's top competitors?
Javelin Pharmaceuticals's top competitors are
Walgreens Boots Alliance
,
Pfizer
,
Cvs Health
,
Novartis
,
Gsk
,
Bayer
What is Javelin Pharmaceuticals's email address?
Javelin Pharmaceuticals's email address is info@javelinpharma.com
What are Javelin Pharmaceuticals's categories?
Javelin Pharmaceuticals's categories are Biotechnology, Developer Platform, Pharmaceutical
What is Javelin Pharmaceuticals's funding?
Javelin Pharmaceuticals's funding is 32,750,000 USD
What is Javelin Pharmaceuticals's current status?
Javelin Pharmaceuticals's current status is acquired
Top Javelin Pharmaceuticals Employees
Vice Chairman, President And Chief Medical Officer
dcarr@javelinpharmaceuticals.com
+1704-332-4454
Manager, Nonclinical Affairs
donna_madden@hotmail.com
Vice President
mmoshman@javelinpharmaceuticals.com
Manager, Clinical Library And Info Svcs
jloescher@javelinpharmaceuticals.com
Chief Executive Officer
mdriscoll@javelinpharma.com
Director Of Supply Chain
rantonucci@javelinpharma.com
Vice President
mmoshman@javelinpharma.com